Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The primary aim of this study was to assess whether the effect of vitamin D supplementation on bone turnover markers and cardiovascular parameters is modified according to vitamin K status at baseline (i.e., serum levels of vitamin K1, MK4 and MK7).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Double-blind reported · Human research reported

Reported blinded roles: participants.

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin K status has no influence on the effect of vitamin D supplementation on bone turnover and cardiovascular markers: a randomized controlled trial

Source: Article title.

This is a post-hoc analysis of the single-center, double-blind, placebo-controlled, parallel-group Styrian Vitamin D Hypertension Trial () carried out at the Medical University of Graz, Austria.

Source: Methods.

Participants were adults aged 18 years or older with arterial hypertension (defined according to guidelines valid at the time of inclusion ()) and a 25(OH)D serum concentration < 30 ng/mL (multiply by 2.496 to convert ng/mL to nmol/L).

Source: Methods.

All investigators/authors enrolling participants, collecting data, and assigning intervention as well as the study participants were blinded to participant allocation.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin K status has no influence on the effect of vitamin D supplementation on bone turnover and cardiovascular markers: a randomized controlled trial

Multiple reported designs · Frontiers in Nutrition · 2026

Original publication title

Vitamin K status has no influence on the effect of vitamin D supplementation on bone turnover and cardiovascular markers: a randomized controlled trial

Verena Theiler-Schwetz; Uwe Riedmann; Sieglinde Zelzer; Andreas Meinitzer; Lisa Schmitt; Daniel Arian Kraus; Christian Trummer; Martin R. Grübler; Martin H. Keppel; Armin Zittermann; Andreas Tomaschitz; Winfried März; Pawel Pludowski; Stefan Pilz

Copyright © 2026 Theiler-Schwetz, Riedmann, Zelzer, Meinitzer, Schmitt, Kraus, Trummer, Grübler, Keppel, Zittermann, Tomaschitz, März, Pludowski and Pilz.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The data from this post-hoc analysis do not provide evidence for the assumption that vitamin K status modifies or enhances effects of vitamin D supplementation on cardiovascular or bone parameters. These findings are in line with current guidelines, which do not routinely recommend vitamin K and D co-treatment in patients with osteoporosis. However, further trials are needed to evaluate the potential benefits of vitamin K supplementation and its combination with vitamin D.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/objectives

Vitamin K and D co-treatment may have additive effects on bone and cardiovascular health and is frequently used as an over-the-counter supplement. The primary aim of this study was to assess whether the effect of vitamin D supplementation on bone turnover markers and cardiovascular parameters is modified according to vitamin K status at baseline (i.e., serum levels of vitamin K1, MK4 and MK7).

Source: Background/objectives

Abstract: What methods does the paper describe?

This is a post-hoc analysis of a randomized controlled vitamin D supplementation (2,800 international units daily for 8 weeks) trial in 200 participants. We measured vitamin K1, MK4 and MK7 by means of the currently available gold standard liquid chromatography tandem mass spectrometric and analysed cardiovascular and bone markers (including 24-h systolic and diastolic blood pressure, glucose and lipid parameters as well as osteocalcin, beta-crosslaps, and procollagen type 1 N-terminal propeptide). The main aim was to analyze whether pre-intervention vitamin K status (moderator) influenced the effects of vitamin D supplementation on outcome measures of bone and cardiovascular health after the intervention (moderation analyses).

We also investigated whether vitamin D supplementation effects vitamin K status and whether vitamin K measures correlated with the outcome parameters.

Source: Methods

Abstract: Results

Moderation analyses showed no significant interaction between vitamin K status and the intervention (vitamin D supplementation/placebo) on cardiovascular or bone parameters. We observed no treatment effect of vitamin D on vitamin K status. In exploratory analyses, parameters of vitamin K status correlated only weakly and inconsistently with some bone and cardiovascular parameters.

Source: Results

Abstract: Conclusion

The data from this post-hoc analysis do not provide evidence for the assumption that vitamin K status modifies or enhances effects of vitamin D supplementation on cardiovascular or bone parameters. These findings are in line with current guidelines, which do not routinely recommend vitamin K and D co-treatment in patients with osteoporosis. However, further trials are needed to evaluate the potential benefits of vitamin K supplementation and its combination with vitamin D.

Source: Conclusion
Authors’ abstract

Background/objectives

Vitamin K and D co-treatment may have additive effects on bone and cardiovascular health and is frequently used as an over-the-counter supplement. The primary aim of this study was to assess whether the effect of vitamin D supplementation on bone turnover markers and cardiovascular parameters is modified according to vitamin K status at baseline (i.e., serum levels of vitamin K1, MK4 and MK7).

Methods

This is a post-hoc analysis of a randomized controlled vitamin D supplementation (2,800 international units daily for 8 weeks) trial in 200 participants. We measured vitamin K1, MK4 and MK7 by means of the currently available gold standard liquid chromatography tandem mass spectrometric and analysed cardiovascular and bone markers (including 24-h systolic and diastolic blood pressure, glucose and lipid parameters as well as osteocalcin, beta-crosslaps, and procollagen type 1 N-terminal propeptide). The main aim was to analyze whether pre-intervention vitamin K status (moderator) influenced the effects of vitamin D supplementation on outcome measures of bone and cardiovascular health after the intervention (moderation analyses).

We also investigated whether vitamin D supplementation effects vitamin K status and whether vitamin K measures correlated with the outcome parameters.

Results

Moderation analyses showed no significant interaction between vitamin K status and the intervention (vitamin D supplementation/placebo) on cardiovascular or bone parameters. We observed no treatment effect of vitamin D on vitamin K status. In exploratory analyses, parameters of vitamin K status correlated only weakly and inconsistently with some bone and cardiovascular parameters.

Conclusion

The data from this post-hoc analysis do not provide evidence for the assumption that vitamin K status modifies or enhances effects of vitamin D supplementation on cardiovascular or bone parameters. These findings are in line with current guidelines, which do not routinely recommend vitamin K and D co-treatment in patients with osteoporosis. However, further trials are needed to evaluate the potential benefits of vitamin K supplementation and its combination with vitamin D.

Publication and source details

Original title: Vitamin K status has no influence on the effect of vitamin D supplementation on bone turnover and cardiovascular markers: a randomized controlled trial

Verena Theiler-Schwetz; Uwe Riedmann; Sieglinde Zelzer; Andreas Meinitzer; Lisa Schmitt; Daniel Arian Kraus; Christian Trummer; Martin R. Grübler; Martin H. Keppel; Armin Zittermann; Andreas Tomaschitz; Winfried März; Pawel Pludowski; Stefan Pilz

Frontiers in Nutrition · 2026

* Correspondence: Verena Theiler-Schwetz, verena.schwetz@medunigraz.at; Uwe Riedmann, uwe.riedmann@medunigraz.at
†

These authors have contributed equally to this work and share first authorship

Copyright © 2026 Theiler-Schwetz, Riedmann, Zelzer, Meinitzer, Schmitt, Kraus, Trummer, Grübler, Keppel, Zittermann, Tomaschitz, März, Pludowski and Pilz.2026Theiler-Schwetz, Riedmann, Zelzer, Meinitzer, Schmitt, Kraus, Trummer, Grübler, Keppel, Zittermann, Tomaschitz, März, Pludowski and Pilzhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. UR is supported by the by the Austrian Science Fund (FWF) KLI 1188. MK was supported by funding of the Austrian National Bank (Jubilaeumsfond: project numbers: 13878 and 13905). AT was partially supported by the project FP7-HEALTH [HEALTH.2011.2.4.2 to 2]; grant agreement number: 278249); and by the project EU-HOMAGE (Validation of-omics-based biomarkers for diseases affecting the elderly [HEALTH.2012.2.1.1 to 2]; grant agreement number: 305507). MG received partial travel support from Amgen Switzerland AG, Switzerland and Synlab Holding Ges.m.b. H. Germany.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-09T20:21:24.863855+00:00

DOI: 10.3389/fnut.2026.1857443 · PMC13365057